A Clinical Study of SPH7854 Granules in Healthy Subjects.

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

111

Participants

Timeline

Start Date

May 28, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Inflammatory Bowel Disease

Interventions

DRUG

SPH7854

SPH7854： Orally, 50-3200mg

DRUG

Placebo

Placebo：Orally；

Trial Locations (1)

RECRUITING

West China Second University Hospital, Sichuan University, Chengdu

All Listed Sponsors

lead

Shanghai Pharmaceuticals Holding Co., Ltd

INDUSTRY